OR WAIT null SECS
April 10, 2020
The guidance answers questions on changes made to the regulatory framework to address challenges during the COVID-19 pandemic.
April 08, 2020
EMA's CHMP has recommended the use of remdesivir, an investigational antiviral medicine, in compassionate use programs across the European Union.
Belgian biopharmaceutical company, UCB, has successfully completed its acquisition of Ra Pharmaceuticals, which is now a wholly-owned subsidiary of the company.
The drug discovery platform was developed to rapidly predict blocking of COVID-19 pneumocyte cellular entry.
The agency has been tasked with coordinating efforts to mitigate shortages of medicines within Europe during the COVID-19 pandemic.
The agency sent a warning letter to Genesis II Church for marketing fraudulent chlorine dioxide products the company claims treats and prevents COVID-19.
April 06, 2020
The partnership, led by Takeda and CSL Behring, will focus on developing a hyperimmune immunoglobulin against COVID-19.
The digital event, called Bio Digital 2020, will now take place from June 8–12, 2020.
April 03, 2020
The medical service volunteer programs will allow their employees who are licensed medical professionals to help fight against COVID-19 while maintaining their base pay.
The acquisition will include PBMI’s trademarks, conference, website, education, and membership assets.